C the Signs is an AI-focused healthcare company that develops a clinical platform for early cancer detection. Its technology operates at the intersection of AI, machine learning, and clinical informatics, directly integrated into primary care systems. The platform analyzes over 1,000 validated data points to assess more than 100 cancer types, providing risk assessments in under 60 seconds.
In real-world clinical use across the United Kingdom, the platform has been adopted by more than 10,000 healthcare professionals in over 1,500 GP practices. It reports a sensitivity of 99% in detecting cancers, contributing to the identification of over 70,000 patients at the earliest stage of disease.
The company was founded by NHS doctors and emphasizes NHS values of equity, access, and care, with a mission to enable early cancer detection for all. Its work operates within the healthcare and oncology verticals, focusing on primary care integration.
